Drugs / FluarixTM
FluarixTM
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT01160237 | Aug 2010 → Feb 2011 | influenza | GlaxoSmithKline | Terminated | No outcome recorded |
| Phase 3 | NCT00866580 | May 2010 → Jul 2011 | influenza | GlaxoSmithKline | Withdrawn | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT01190215 | Oct 2010 → Jul 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT00750360 | Oct 2003 → Dec 2007 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Also used as a comparator or background therapy in 4 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00385840 Comparator | Oct 2006 → Feb 2007 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT01196988 Comparator | Oct 2010 → Jun 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT01204671 Comparator | Oct 2010 → Jun 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00992784 Comparator | Oct 2009 → May 2010 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FluarixTM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01160237 ↗ |
| Known as | Fluarix | “GlaxoSmithKline Biologicals' Influenza Split Vaccine FLUARIX™ Administered According to the Prescribing Information” NCT00750360 ↗1“Subjects received one dose of the Fluarix™ vaccine at Day 0.” NCT01204671 ↗ |
| Known as | Influsplit SSW 2010/2011 | “Biological: FluarixTM/ Influsplit SSW® 2010/2011” NCT01160237 ↗ |
| Modality | Vaccine | “Fluarix™ vaccine” NCT00385840 ↗ |
| Route | Intramuscular | “Intramuscular dose on Day 42 or on Day -30, according to the vaccination schedule” NCT00866580 ↗ |